• Blog
  • Veno Arterial ECMO System Market Report

    Veno Arterial ECMO System Market Report

    Veno Arterial ECMO System Market Report
    Report code - SR1324 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Veno-Arterial ECMO System Market Trends, Dynamics & Market Insights
    See more...

    Impact of COVID-19 on Veno Arterial ECMO System Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Veno Arterial ECMO System Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Veno-Arterial ECMO System market is projected to grow from USD 262.3 million in 2020 to USD 326.5 million by 2026 at a CAGR of around 3.8% during the forecast period.

    Figure: Veno-Arterial ECMO System Market Size, 2020-2026 (USD Million)

    Veno-Arterial-ECMO-System-Market-Forecast

    Wish to get a free sample? Register Here

    What is veno-arterial ECMO system?

    Veno-arterial extracorporeal membrane oxygenation (ECMO) also referred to as extracorporeal life support will be defined as a type of temporary mechanical circulatory support and simultaneous extracorporeal gas exchange. It's emerged as a salvage intervention in patients with cardiogenic shock, even cardiopulmonary arrest refractory to plain therapies.

    Key Players

    Key players operating in the Veno-Arterial ECMO System market are-

    • Sorin Group (Italy)
    • Medtronic plc (Ireland)
    • MAQUET Holding B.V. & Co. KG (Germany)
    • Terumo Corporation (Japan)
    • Xenios AG (Germany)
    • Nipro Corporation (Japan)
    • MicroPort (China)
    • CORMED Medizintechnik GmbH & Co. KG (Germany)
    • Medos Medizintechnik AG (Germany)
    • LivaNova, PLC (UK)
    • CytoSorbents Corporation (US).

    Market Dynamics

    The growth of Veno-Arterial ECMO System market is primarily driven by rising incidences of pulmonary diseases and cardiac arrest. Increasing prevalence of heart related diseases due to stress and unhealthy eating habits is likely to propel the market growth at a significant rate during the review period. In addition to this, rising demand for technologically advanced veno-arterial ECMO system is likely to create lucrative opportunities for the players operating in the global market in the coming years.

    Segment Analysis

    Application Trends

    By application, the veno-arterial ECMO system market has been bifurcated into neonatal, pediatric and adult. Under these, the adult segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period.

    Regional Trends

    By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The regional growth can be attributed to high product adoption rate and presence of key market players such as CytoSorbents Corporation (US). The market growth in Asia-Pacific region is expected to be driven by rising number of patients having pulmonary or cardiovascular diseases.

    COVID-19 Impact on Veno-Arterial ECMO System Market

    The covid-19 outbreak posed significant challenges on the various verticals across geographies. It impacted the growth of the veno-arterial ECMO system market negatively for a short period of time as imposition of complete lockdown and restrictions on trade affected the product supply.

    Critical Questions Answered in the Report

    • What are the key trends in the Veno-Arterial ECMO System market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in next five years?
    • What is the impact of COVID-19 on Veno-Arterial ECMO System market?
    • What are the key strategies adopted by the major vendors to lead in the Veno-Arterial ECMO System market?
    • What is the market share of the top vendors?

    Get the full scope of the report. Register Here

    Target Audience

    Here is the list of the group of customers that the veno-arterial ECMO system market hopes to have the greatest opportunity to convert-

    • Veno-arterial ECMO system distributors
    • Veno-arterial ECMO system suppliers
    • Veno-arterial ECMO system manufacturers
    • Logistics organizations
    • Government bodies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The veno-arterial ECMO system market is expected to witness an impressive growth of 3.8% CAGR in the coming years.

    Sorin Group (Italy), Medtronic plc (Ireland), MAQUET Holding B.V. & Co. KG (Germany), Terumo Corporation (Japan), Xenios AG (Germany), Nipro Corporation (Japan), MicroPort (China), CORMED Medizintechnik GmbH & Co. KG (Germany), Medos Medizintechnik AG (Germany), LivaNova, PLC (UK), CytoSorbents Corporation (US) are among the key players in the veno-arterial ECMO system market.

    The veno-arterial ECMO system market size is expected to reach USD 326.5 million in the foreseeable future.

    Adult segment accounted for the largest share in the veno-arterial ECMO system market in 2020.

    North America is expected to grow at a significant CAGR in the veno-arterial ECMO system market during the next five years.

    Veno-arterial ECMO system distributors, Veno-arterial ECMO system suppliers, Veno-arterial ECMO system manufacturers, Logistics organizations, Government bodies are the target audience in the veno-arterial ECMO system market.

    •